Managing thrombosis in cancer patients

被引：35
|
作者：
Wang, Tzu-Fei [1 ]
Li, Ang [2 ]
Garcia, David [2 ]
机构：
[1] Ohio State Univ, Div Hematol, Columbus, OH 43210 USA
[2] Univ Washington, Sch Med, Div Hematol, Seattle, WA 98195 USA
来源：
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS | 2018年 / 2卷 / 03期
基金：
美国国家卫生研究院;
关键词：
anticoagulation; cancer-associated thrombosis; deep vein thrombosis; malignancy; pulmonary embolism; Venous thromboembolism; RECURRENT VENOUS THROMBOEMBOLISM; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; ACTIVE CANCER; P-SELECTIN; INTRACRANIAL HEMORRHAGE; SECONDARY PREVENTION; PULMONARY-EMBOLISM; DOSE-ESCALATION; TISSUE FACTOR;
D O I：
10.1002/rth2.12102
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Venous thromboembolism is a major complication in cancer patients. The basis for the strong association between cancer and thrombosis remains incompletely understood, and the optimal approaches to both the treatment and the prevention of cancer-associated thrombosis are evolving. Here we review several important topics related to cancer-associated thromboembolism, including the pathogenesis, prevention, and management of this disease. Wherever possible, we include evidence from clinical trials, including the results of recently published trials that compared direct oral anticoagulants to low-molecular-weight heparin for the treatment of cancer-associated thrombosis.
引用
收藏
页码：429 / 438
页数：10
相关论文
共 50 条
  • [21] Arterial and Venous Thrombosis in Cancer Patients
    Blann, Andrew D.
    Dunmore, Simon
    CARDIOLOGY RESEARCH AND PRACTICE, 2011, 2011
  • [22] Thrombosis risk in Mexican patients with cancer
    Villanueva, AG
    Gallardo, D
    Valdespino, V
    Coronel, J
    Rodarte, G
    Alvarez, S
    Torrecillas, L
    Cervantes, G
    Galicia, J
    ANNALS OF ONCOLOGY, 2005, 16 : 320 - 320
  • [23] Blood Clots, or Thrombosis, in Patients With Cancer
    Litt, Henry K.
    Parks, Anna L.
    Velazquez, Ana I.
    JAMA ONCOLOGY, 2023, 9 (06) : 876 - 876
  • [24] Cancer associated thrombosis in pediatric patients
    Barg, Assaf Arie
    Kenet, Gili
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022, 35 (01)
  • [25] Rethinking the approach to thrombosis in patients with cancer
    Khorana, Alok A.
    VASCULAR MEDICINE, 2020, 25 (03) : 208 - 209
  • [26] Prevention of Thrombosis in Ambulatory Patients With Cancer
    Rana, Punam
    Levine, Mark N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (29) : 4885 - 4888
  • [27] THROMBOSIS AND BLEEDING IN CANCER-PATIENTS
    PEUSCHER, FW
    NETHERLANDS JOURNAL OF MEDICINE, 1981, 24 (01): : 23 - 35
  • [28] Characterization of thrombosis risk in patients with cancer
    Cerezuela, Pablo
    Castellon, Victoria
    Salgado, Mercedes
    Martinez de Castro, Eva
    Martinez, Purificacion
    Molina, Raquel
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 58 - 59
  • [29] Central line thrombosis in patients with cancer
    Bona, RD
    CURRENT OPINION IN PULMONARY MEDICINE, 2003, 9 (05) : 362 - 366
  • [30] SEOM guidelines on thrombosis in cancer patients
    Andrés J. Muñoz
    Nuria Viñolas
    Ricardo Cubedo
    Dolores Isla
    Clinical and Translational Oncology, 2011, 13 : 592 - 596
12345